Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Neuraxis, Inc. (NRXS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/23/2025: NRXS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $5.88
1 Year Target Price $5.88
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -19.05% | Avg. Invested days 46 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 37.71M USD | Price to earnings Ratio - | 1Y Target Price 5.88 |
Price to earnings Ratio - | 1Y Target Price 5.88 | ||
Volume (30-day avg) 1 | Beta 3.19 | 52 Weeks Range 1.33 - 3.99 | Updated Date 10/24/2025 |
52 Weeks Range 1.33 - 3.99 | Updated Date 10/24/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.05 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -222.91% | Operating Margin (TTM) -190.85% |
Management Effectiveness
Return on Assets (TTM) -83.58% | Return on Equity (TTM) -2480.49% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 25920074 | Price to Sales(TTM) 11.72 |
Enterprise Value 25920074 | Price to Sales(TTM) 11.72 | ||
Enterprise Value to Revenue 8.06 | Enterprise Value to EBITDA -4.39 | Shares Outstanding 9872776 | Shares Floating 6876849 |
Shares Outstanding 9872776 | Shares Floating 6876849 | ||
Percent Insiders 20.39 | Percent Institutions 15.54 |
Upturn AI SWOT
Neuraxis, Inc.
Company Overview
History and Background
I cannot provide details about Neuraxis, Inc. as this company does not exist.
Core Business Areas
Leadership and Structure
I cannot provide details about Neuraxis, Inc. as this company does not exist.
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
I cannot provide details about Neuraxis, Inc. as this company does not exist.
Positioning
I cannot provide details about Neuraxis, Inc. as this company does not exist.
Total Addressable Market (TAM)
I cannot provide details about Neuraxis, Inc. as this company does not exist.
Upturn SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Competitors and Market Share
Key Competitors
Competitive Landscape
I cannot provide details about Neuraxis, Inc. as this company does not exist.
Growth Trajectory and Initiatives
Historical Growth: I cannot provide details about Neuraxis, Inc. as this company does not exist.
Future Projections: I cannot provide details about Neuraxis, Inc. as this company does not exist.
Recent Initiatives: I cannot provide details about Neuraxis, Inc. as this company does not exist.
Summary
I cannot analyze Neuraxis, Inc. as the company does not exist. Therefore, I can not assess its strengths, weaknesses, market position, or potential future challenges. The analysis depends on real-world data which is not possible as the comapny is non existent.
Peer Comparison
Sources and Disclaimers
Data Sources:
- N/A
Disclaimers:
No data available for Neuraxis, Inc. as it is not a real company. The analysis is based on the assumption of non-existence. This response is generated by AI based on the user's prompt, it has no affiliation with an actual company
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Neuraxis, Inc.
Exchange NYSE MKT | Headquaters Carmel, IN, United States | ||
IPO Launch date 2023-08-09 | President, CEO & Director Mr. Brian Carrico | ||
Sector Healthcare | Industry Biotechnology | Full time employees 21 | Website https://neuraxis.com |
Full time employees 21 | Website https://neuraxis.com | ||
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.